$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Efficiency Alleles of the Pctr1 Modifier Locus for Plasmacytoma Susceptibility 원문보기

Molecular and cellular biology, v.21 no.1, 2001년, pp.310 - 318  

Zhang, Shuling-L. (Laboratory of Genetics) ,  DuBois, Wendy (Laboratory of Genetics) ,  Ramsay, Edward S. (Laboratory of Genetics) ,  Bliskovski, Valeri (Laboratory of Genetics) ,  Morse III, Herbert C. (Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892) ,  Taddesse-Heath, Leki (Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892) ,  Vass, William C. (Laboratory of Cellular Oncology, Division of Basic Sciences, National Cancer Institute) ,  DePinho, Ronald A. (Department of Adult Oncology, Dana-Farber Cancer Institute, and Departments of Genetics and Medicine, Harvard Medical School, Boston, Massachusetts 02115) ,  Mock, Beverly A. (Laboratory of Genetics)

Abstract AI-Helper 아이콘AI-Helper

ABSTRACT The susceptibility of BALB/c mice to pristane-induced plasmacytomas is a complex genetic trait involving multiple loci, while DBA/2 and C57BL/6 strains are genetically resistant to the plasmacytomagenic effects of pristane. In this model system for human B-cell neoplasia, one of the BALB/c ...

참고문헌 (47)

  1. Ahmad, N. Nina, Barbosa de Melo, Mônica, Singh, Arun D., Donoso, Larry A., Shields, Jerry A.. A possible hot spot in exon 21 of the retinoblastoma gene predisposing to a low penetrant retinoblastoma phenotype?. Ophthalmic genetics, vol.20, no.4, 225-231.

  2. Bates, Stewart, Phillips, Andrew C., Clark, Paula A., Stott, Francesca, Peters, Gordon, Ludwig, Robert L., Vousden, Karen H.. p14ARF links the tumour suppressors RB and p53. Nature, vol.395, no.6698, 124-125.

  3. Brown, Robert T., Ades, Ibrahim Z., Nordan, Richard P.. An Acute Phase Response Factor/NF-κB Site Downstream of the junB Gene That Mediates Responsiveness to Interleukin-6 in a Murine Plasmacytoma. The Journal of biological chemistry, vol.270, no.52, 31129-31135.

  4. Carter, Angela M., Catto, Andrew J., Grant, Peter J.. Association of the α-Fibrinogen Thr312Ala Polymorphism With Poststroke Mortality in Subjects With Atrial Fibrillation. Circulation, vol.99, no.18, 2423-2426.

  5. Proc. Natl. Acad. Sci. USA Clynes R. J. 6067 85 1988 10.1073/pnas.85.16.6067 

  6. Cormier, Robert T., Hong, Karen H., Halberg, Richard B., Hawkins, Trevor L., Richardson, Paul, Mulherkar, Rita, Dove, William F., Lander, Eric S.. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nature genetics, vol.17, no.1, 88-91.

  7. Dietrich, W.F., Lander, E.S., Smith, J.S., Moser, A.R., Gould, K.A., Luongo, C., Borenstein, N., Dove, W.. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, vol.75, no.4, 631-639.

  8. Blood Dilworth D. 1869 95 1999 10.1182/blood.V95.5.1869.005k09_1869_1871 

  9. Drexler, H G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cells. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, vol.12, no.6, 845-859.

  10. Farker, K., Lehmann, M.H., Kästner, R., Weber, J., Janitzky, V., Schubert, J., Hoffmann, A.. Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population. International journal of clinical pharmacology and therapeutics, vol.38, no.1, 30-34.

  11. Mol. Diagn. Ford M. E. 211 4 1999 10.1016/S1084-8592(99)80024-1 

  12. Haidar, MA, Cao, XB, Manshouri, T, Chan, LL, Glassman, A, Kantarjian, HM, Keating, MJ, Beran, MS, Albitar, M. p16INK4A and p15INK4B gene deletions in primary leukemias. Blood, vol.86, no.1, 311-315.

  13. Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., Pease, L.R.. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene, vol.77, no.1, 51-59.

  14. BioTechniques Jiang W. 348 24 1998 10.2144/98243bm03 

  15. Kamijo, Takehiko, Zindy, Frederique, Roussel, Martine F., Quelle, Dawn E., Downing, James R., Ashmun, Richard A., Grosveld, Gerard, Sherr, Charles J.. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF. Cell, vol.91, no.5, 649-659.

  16. Klangby, Ulf, Okan, Ismail, Magnusson, Kristinn P., Wendland, Martin, Lind, Peter, Wiman, Klas G.. p16/INK4a and p15/INK4b Gene Methylation and Absence of p16/INK4a mRNA and Protein Expression in Burkitt's Lymphoma. Blood, vol.91, no.5, 1680-1687.

  17. Koh, James, Enders, Greg H., David Dynlacht, Brian, Harlow, Ed. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, vol.375, no.6531, 506-510.

  18. Leukemia Kovalchuk A. L. 909 14 2000 10.1038/sj.leu.2401676 

  19. MacPhee, Melina, Chepenik, Kenneth P, Liddell, Rebecca A, Nelson, Kelly K, Siracusa, Linda D, Buchberg, Arthur M. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell, vol.81, no.6, 957-966.

  20. Curr. Top. Microbiol. Immunol. Mock B. 125 141 1988 

  21. Mock, Beverly A., Hartley, Janet, Le Tissier, Paul, Wax, Judith S., Potter, Michael. The Plasmacytoma Resistance Gene, Pctr2, Delays the Onset of Tumorigenesis and Resides in the Telomeric Region of Chromosome 4. Blood, vol.90, no.10, 4092-4098.

  22. Mock, B A, Krall, M M, Dosik, J K. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.. Proceedings of the National Academy of Sciences of the United States of America, vol.90, no.20, 9499-9503.

  23. Neumann, Carola, Zehentmaier, Gundula, Danhauser‐Riedl, Susanne, Emmerich, Bertold, Hallek, Michael. Interleukin‐6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP‐1. European journal of immunology, vol.26, no.2, 379-384.

  24. Cell Growth Differ. Nevins J. R. 585 9 1998 

  25. Ng, M.H.L., Chung, Y.F., Lo, K.W., Wickham, N.W.R., Lee, J.C.K., Huang, D.P.. Frequent Hypermethylation of p16 and p15 Genes in Multiple Myeloma. Blood, vol.89, no.7, 2500-2506.

  26. Ogata, A, Chauhan, D, Teoh, G, Treon, S P, Urashima, M, Schlossman, R L, Anderson, K C. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.. The journal of immunology : official journal of the American Association of Immunologists, vol.159, no.5, 2212-2221.

  27. Pomerantz, Jason, Schreiber-Agus, Nicole, Liégeois, Nanette J, Silverman, Adam, Alland, Leila, Chin, Lynda, Potes, Jason, Chen, Ken, Orlow, Irene, Lee, Han-Woong, Cordon-Cardo, Carlos, DePinho, Ronald A. The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53. Cell, vol.92, no.6, 713-723.

  28. Cancer Res. Potter M. 969 54 1994 

  29. Potter, Michael, Robertson, Charlotte L.. Development of Plasma-Cell Neoplasms in BALB/c Mice After Intraperitoneal Injection of Paraffin-Oil Adjuvant, Heat-Killed Staphylococcus Mixtures. Journal of the National Cancer Institute: JNCI, vol.25, no.4, 847-861.

  30. Quelle, Dawn E., Cheng, Mangeng, Ashmun, Richard A., Sherr, Charles J.. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16 INK4a but not by the alternative reading frame protein p19 ARF. Proceedings of the National Academy of Sciences of the United States of America, vol.94, no.2, 669-673.

  31. Ouelle, Dawn E., Zindy, Frédérique, Ashmun, Richard A., Sherr, Charles J.. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, vol.83, no.6, 993-1000.

  32. Quesnel, Bruno, Preudhomme, Claude, Fenaux, Pierre. p16ink4a Gene and Hematological Malignancies. Leukemia & lymphoma, vol.22, no.1, 11-24.

  33. Robles, Ana I, Wang, Xin W, Harris, Curtis C. Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death. Oncogene, vol.18, no.33, 4681-4688.

  34. Molecular cloning: a laboratory manual Sambrook J. 1989 2 

  35. 10.1182/blood.V94.2.748 

  36. Serrano, Manuel, Lee, Han-Woong, Chin, Lynda, Cordon-Cardo, Carlos, Beach, David, DePinho, Ronald A. Role of the INK4a Locus in Tumor Suppression and Cell Mortality. Cell, vol.85, no.1, 27-37.

  37. Blood Shacter E. 194 80 1992 10.1182/blood.V80.1.194.194 

  38. Tanaka, Hiroshi, Arakawa, Hirofumi, Yamaguchi, Tatsuya, Shiraishi, Kenji, Fukuda, Seisuke, Matsui, Kuniko, Takei, Yoshiki, Nakamura, Yusuke. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature, vol.404, no.6773, 42-49.

  39. Tao, Weikang, Levine, Arnold J.. P19 ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proceedings of the National Academy of Sciences of the United States of America, vol.96, no.12, 6937-6941.

  40. Tasaka, Taizo, Berenson, James, Vescio, Robert, Hirama, Toshiyasu, Miller, Carl W., Nagai, Masami, Takahara, Jiro, Koeffler, H. Phillip. Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma. British journal of haematology, vol.96, no.1, 98-102.

  41. J. Med. Genet. Wallis Y. L. 14 36 1999 

  42. Weinberg, Robert A. The retinoblastoma protein and cell cycle control. Cell, vol.81, no.3, 323-330.

  43. Cancer Res. Wiener F. 1181 55 1995 

  44. Mol. Cell. Biol. Willumsen B. M. 6026 9 1991 

  45. Zhang, Shuling, Ramsay, Edward S., Mock, Beverly A.. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4aand p19ARF, is a candidate for the plasmacytoma susceptibility locus,Pctr1. Proceedings of the National Academy of Sciences of the United States of America, vol.95, no.5, 2429-2434.

  46. Zhang, Yanping, Xiong, Yue. Mutations in Human ARF Exon 2 Disrupt Its Nucleolar Localization and Impair Its Ability to Block Nuclear Export of MDM2 and p53. Molecular cell, vol.3, no.5, 579-591.

  47. Zhang, Yanping, Xiong, Yue, Yarbrough, Wendell G. ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways. Cell, vol.92, no.6, 725-734.

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로